Int J Stomatol ›› 2022, Vol. 49 ›› Issue (2): 244-248.doi: 10.7518/gjkq.2022019
• Reviews • Previous Articles
Jiang Duan(),Shen Daonan,Zhao Lei,Wu Yafei()
CLC Number:
[1] |
Hajishengallis G, Chavakis T. DEL-1-regulated immune plasticity and inflammatory disorders[J]. Trends Mol Med, 2019, 25(5): 444-459.
doi: S1471-4914(19)30045-0 pmid: 30885428 |
[2] |
Suárez LJ, Garzón H, Arboleda S, et al. Oral dysbiosis and autoimmunity: from local periodontal responses to an imbalanced systemic immunity. A review[J]. Front Immunol, 2020, 11: 591255.
doi: 10.3389/fimmu.2020.591255 pmid: 33363538 |
[3] |
Choi EY, Chavakis E, Czabanka MA, et al. Del-1, an endogenous leukocyte-endothelial adhesion inhibitor, limits inflammatory cell recruitment[J]. Science, 2008, 322(5904): 1101-1104.
doi: 10.1126/science.1165218 |
[4] | Shin J, Hosur KB, Pyaram K, et al. Expression and function of the homeostatic molecule Del-1 in endothelial cells and the periodontal tissue[J]. Clin Dev Immunol, 2013, 2013: 617809. |
[5] |
Inönü E, Kayis SA, Eskan MA, et al. Salivary Del-1, IL-17, and LFA-1 levels in periodontal health and disease[J]. J Periodontal Res, 2020, 55(4): 511-518.
doi: 10.1111/jre.12738 pmid: 32153040 |
[6] |
Folwaczny M, Karnesi E, Berger T, et al. Clinical association between chronic periodontitis and the leukocyte extravasation inhibitors developmental endothelial locus-1 and pentraxin-3[J]. Eur J Oral Sci, 2017, 125(4): 258-264.
doi: 10.1111/eos.12357 pmid: 28643381 |
[7] |
Khader SA. Restraining IL-17: Del-1 deals the blow[J]. Nat Immunol, 2012, 13(5): 433-435.
doi: 10.1038/ni.2290 |
[8] |
Eskan MA, Jotwani R, Abe T, et al. The leukocyte integrin antagonist Del-1 inhibits IL-17-mediated inflammatory bone loss[J]. Nat Immunol, 2012, 13(5): 465-473.
doi: 10.1038/ni.2260 |
[9] |
Klotzsche-von Ameln A, Cremer S, Hoffmann J, et al. Endogenous developmental endothelial locus-1 limits ischaemia-related angiogenesis by blocking inflammation[J]. Thromb Haemost, 2017, 117(6): 1150-1163.
doi: 10.1160/TH16-05-0354 |
[10] |
Kourtzelis I, Li XF, Mitroulis I, et al. DEL-1 promotes macrophage efferocytosis and clearance of inflammation[J]. Nat Immunol, 2019, 20(1): 40-49.
doi: 10.1038/s41590-018-0249-1 pmid: 30455459 |
[11] |
Rosas M, Davies LC, Giles PJ, et al. The transcription factor Gata6 links tissue macrophage phenotype and proliferative renewal[J]. Science, 2014, 344(6184): 645-648.
doi: 10.1126/science.1251414 |
[12] |
Hajishengallis G, Korostoff JM. Revisiting the Page & Schroeder model: the good, the bad and the unknowns in the periodontal host response 40 years later[J]. Periodontol 2000, 2017, 75(1): 116-151.
doi: 10.1111/prd.12181 pmid: 28758305 |
[13] |
Dasgupta SK, Le A, Chavakis T, et al. Developmental endothelial locus-1 (Del-1) mediates clearance of platelet microparticles by the endothelium[J]. Circulation, 2012, 125(13): 1664-1672.
doi: 10.1161/CIRCULATIONAHA.111.068833 pmid: 22388320 |
[14] |
Bednarczyk M, Stege H, Grabbe S, et al. β2 inte-grins-multi-functional leukocyte receptors in health and disease[J]. Int J Mol Sci, 2020, 21(4): 1402.
doi: 10.3390/ijms21041402 |
[15] |
Cortés-Vieyra R, Rosales C, Uribe-Querol E. Neutrophil functions in periodontal homeostasis[J]. J Immunol Res, 2016, 2016: 1396106.
doi: 10.1155/2016/1396106 pmid: 27019855 |
[16] |
Hajishengallis G. New developments in neutrophil biology and periodontitis[J]. Periodontol 2000, 2020, 82(1): 78-92.
doi: 10.1111/prd.12313 pmid: 31850633 |
[17] |
Saxena S, Venugopal R, Chandrayan Rao R, et al. Association of chronic periodontitis and type 2 diabetes mellitus with salivary Del-1 and IL-17 levels[J]. J Oral Biol Craniofac Res, 2020, 10(4): 529-534.
doi: 10.1016/j.jobcr.2020.08.013 pmid: 32874883 |
[18] |
Mahilkar S, Malagi SK, Soni A, et al. IL-17, A possible salivary biomarker for preterm birth in females with periodontitis[J]. J Obstet Gynaecol India, 2021, 71(3): 262-267.
doi: 10.1007/s13224-021-01466-1 |
[19] |
Maekawa T, Hosur K, Abe T, et al. Antagonistic effects of IL-17 and D-resolvins on endothelial Del-1 expression through a GSK-3β-C/EBPβ pathway[J]. Nat Commun, 2015, 6: 8272.
doi: 10.1038/ncomms9272 pmid: 26374165 |
[20] |
Ziogas A, Maekawa T, Wiessner JR, et al. DHEA inhibits leukocyte recruitment through regulation of the integrin antagonist DEL-1[J]. J Immunol, 2020, 204(5): 1214-1224.
doi: 10.4049/jimmunol.1900746 |
[21] | Stańdo M, Piatek P, Namiecinska M, et al. Omega-3 polyunsaturated fatty acids EPA and DHA as an adjunct to non-surgical treatment of periodontitis: a randomized clinical trial[J]. Nutrients, 2020, 12(9): E2614. |
[22] | Maekawa T, Tamura H, Domon H, et al. Erythromycin inhibits neutrophilic inflammation and mucosal disease by upregulating DEL-1[J]. JCI Insight, 2020, 5(15): 136706. |
[23] |
Fujimura T, Mitani A, Fukuda M, et al. Irradiation with a low-level diode Laser induces the developmental endothelial locus-1 gene and reduces proinflammatory cytokines in epithelial cells[J]. Lasers Med Sci, 2014, 29(3): 987-994.
doi: 10.1007/s10103-013-1439-6 |
[24] | Tamura H, Maekawa T, Domon H, et al. Effects of erythromycin on osteoclasts and bone resorption via DEL-1 induction in mice[J]. Antibiotics (Basel), 2021, 10(3): 312. |
[25] |
Kajikawa T, Meshikhes F, Maekawa T, et al. Milk fat globule epidermal growth factor 8 inhibits perio-dontitis in non-human primates and its gingival crevicular fluid levels can differentiate periodontal health from disease in humans[J]. J Clin Periodontol, 2017, 44(5): 472-483.
doi: 10.1111/jcpe.2017.44.issue-5 |
[26] |
Siddiqui YD, Omori K, Ito T, et al. Resolvin D2 induces resolution of periapical inflammation and promotes healing of periapical lesions in rat periapical periodontitis[J]. Front Immunol, 2019, 10: 307.
doi: 10.3389/fimmu.2019.00307 pmid: 30863409 |
[27] |
Li X, Colamatteo A, Kalafati L, et al. The DEL-1/β3 integrin axis promotes regulatory T cell responses during inflammation resolution[J]. J Clin Invest, 2020, 130(12): 6261-6277.
doi: 10.1172/JCI137530 |
[28] |
Alvarez C, Suliman S, Almarhoumi R, et al. Regulatory T cell phenotype and anti-osteoclastogenic function in experimental periodontitis[J]. Sci Rep, 2020, 10(1): 19018.
doi: 10.1038/s41598-020-76038-w pmid: 33149125 |
[29] | Shin J, Maekawa T, Abe T, et al. DEL-1 restrains osteoclastogenesis and inhibits inflammatory bone loss in nonhuman primates[J]. Sci Transl Med, 2015, 7(307): 307ra155. |
[30] | Kang JY, Kang N, Yang YM, et al. The role of Ca2+-NFATc1 signaling and its modulation on osteoclastogenesis[J]. Int J Mol Sci, 2020, 21(10): E3646. |
[31] |
Mitroulis I, Kang YY, Gahmberg CG, et al. Deve-lopmental endothelial locus-1 attenuates complement-dependent phagocytosis through inhibition of Mac-1-integrin[J]. Thromb Haemost, 2014, 111(5): 1004-1006.
doi: 10.1160/TH13-09-0794 |
[32] | Maekawa T, Kobayashi Y, Domon H, et al. Local regulator del1 inhibits bone-resorption via suppression of Wnt5a-Ror2 signaling axis[J]. J Bone Miner Res, 2018, 33: 257. |
[33] |
Uehara S, Udagawa N, Kobayashi Y. Regulation of osteoclast function via Rho-Pkn3-c-Src pathways[J]. J Oral Biosci, 2019, 61(3): 135-140.
doi: 10.1016/j.job.2019.07.002 |
[34] |
Yuh DY, Maekawa T, Li X, et al. The secreted protein DEL-1 activates a beta3 integrin-FAK-ERK1/2-RUNX2 pathway and promotes osteogenic differentiation and bone regeneration[J]. J Biol Chem, 2020, 295(21): 7261-7273.
doi: 10.1074/jbc.RA120.013024 |